MDFR Stock Overview
Medifarm a.d. Beograd trades and supplies pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Medifarm a.d. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | дин60.00 |
| 52 Week High | дин60.00 |
| 52 Week Low | дин60.00 |
| Beta | 0 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -70.59% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| MDFR | RS Trade Distributors | RS Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | -0.8% |
| 1Y | n/a | -1.6% | 13.7% |
Return vs Industry: Insufficient data to determine how MDFR performed against the RS Trade Distributors industry.
Return vs Market: Insufficient data to determine how MDFR performed against the RS Market.
Price Volatility
| MDFR volatility | |
|---|---|
| MDFR Average Weekly Movement | n/a |
| Trade Distributors Industry Average Movement | 3.8% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in RS Market | 9.1% |
| 10% least volatile stocks in RS Market | 2.3% |
Stable Share Price: MDFR's share price has been volatile over the past 3 months compared to the RS market.
Volatility Over Time: Insufficient data to determine MDFR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.medifarm.rs |
Medifarm a.d. Beograd trades and supplies pharmaceutical products. The company is based in Beograd, Serbia.
Medifarm a.d. Fundamentals Summary
| MDFR fundamental statistics | |
|---|---|
| Market cap | дин92.89m |
| Earnings (TTM) | дин0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MDFR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDFR income statement (TTM) | |
|---|---|
| Revenue | дин0 |
| Cost of Revenue | дин0 |
| Gross Profit | дин0 |
| Other Expenses | дин0 |
| Earnings | дин0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MDFR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 23:24 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medifarm a.d. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|